Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

2012 Wild Card: Will Guideline Revisions Drive Demand For Better Drugs?

23 Apr 2012

Related Content

Merck/Schering Vytorin Launch Could Be Aided By New Cholesterol Guidelines

19 Jul 2004

Branded Life After <em>Lipitor</em>: Pharma Targets Unmet Needs In Dyslipidemia

23 Apr 2012

NCEP Statin Recommendations Challenged By CSPI, Researchers

04 Oct 2004

Related Companies

Mount Sinai Health System

University of North Carolina

Merck & Co., Inc.

Additional Topics

Research & Development BioPharmaceutical

More from Archive

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.